Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 |Industry: Pharmaceuticals
|Expensive Performer

Aurobindo Pharma Ltd.    
13 Mar 2019
Angel Broking
Aurobindo Pharmaceuticals (APL) has a big relief in form of Establishment Inspection report (EIR) for Unit-4 facility in which the USFDA has closed issued Form 483. The Form 483 is issued to a firms management at the conclusion of an inspection when an investigator(s) has observed any conditions that may constitute violations of the Food
Aurobindo Pharma Ltd. has an average target of 894.40 from 12 brokers.
More from Aurobindo Pharma Ltd.